{
  "ticker": "BMY",
  "last_updated": "2025-04-19T08:57:46.400210",
  "retention_years": 3,
  "count": 144,
  "transactions": [
    {
      "id": 195770,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-11-04",
      "transaction_shares": "700",
      "transaction_price": "55.615",
      "transaction_type": "S",
      "shares_after_transaction": "11760"
    },
    {
      "id": 228691,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-11-04",
      "transaction_shares": "700",
      "transaction_price": "55.615",
      "transaction_type": "S",
      "shares_after_transaction": "11760"
    },
    {
      "id": 195783,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1830",
      "transaction_price": "54.675",
      "transaction_type": "P",
      "shares_after_transaction": "62109"
    },
    {
      "id": 195807,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-11-01",
      "transaction_shares": "2964",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "104169"
    },
    {
      "id": 228704,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1830",
      "transaction_price": "54.675",
      "transaction_type": "P",
      "shares_after_transaction": "62109"
    },
    {
      "id": 228728,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-11-01",
      "transaction_shares": "2964",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "104169"
    },
    {
      "id": 165185,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-10-02",
      "transaction_shares": "4558",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6667"
    },
    {
      "id": 195804,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-10-02",
      "transaction_shares": "4558",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6667"
    },
    {
      "id": 228725,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-10-02",
      "transaction_shares": "4558",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6667"
    },
    {
      "id": 110815,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1061",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2493"
    },
    {
      "id": 136991,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1061",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2493"
    },
    {
      "id": 165146,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1061",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2493"
    },
    {
      "id": 195761,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1061",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2493"
    },
    {
      "id": 228682,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1061",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2493"
    },
    {
      "id": 27778,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 44821,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 64582,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 86552,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 110812,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 136988,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 165142,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 195757,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 228678,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3306",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6532"
    },
    {
      "id": 14770,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 14772,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 14775,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 14776,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 14778,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 14780,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 14781,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 14782,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 14783,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 14784,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 14788,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 27781,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 27784,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 27788,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 27789,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 27792,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 27795,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 27796,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 27797,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 27798,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 27799,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 27804,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 44824,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 44827,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 44831,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 44832,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 44835,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 44839,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 44840,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 44841,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 44842,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 44843,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 44848,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 64585,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 64588,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 64592,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 64593,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 64596,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 64600,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 64601,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 64602,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 64603,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 64604,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 64609,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 86556,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 86559,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 86565,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 86566,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 86569,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 86576,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 86577,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 86578,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 86579,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 86580,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 86585,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 110818,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 110821,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 110827,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 110828,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 110831,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 110838,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 110839,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 110840,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 110841,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 110842,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 110847,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 136994,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 136997,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 137003,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 137004,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 137007,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 137014,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 137015,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 137016,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 137017,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 137018,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 137023,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 165149,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 165154,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 165161,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 165162,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 165166,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 165173,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 165174,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 165175,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 165176,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 165178,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 165183,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 195764,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 195769,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 195777,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 195778,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 195784,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 195791,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 195792,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 195793,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 195794,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 195796,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 195802,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 228685,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 228690,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 228698,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 228699,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 228705,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 228712,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 228713,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 228714,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 228715,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 228717,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 228723,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 4720,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 14785,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 27800,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 44844,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 64605,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 86581,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 110843,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 137019,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 165179,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 195797,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 228718,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    }
  ]
}